Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
66JPY
7.65 BJPY
51.39 BJPY
31.56 M
About GMO FINANCIAL HOLDINGS INC
Sector
Industry
Headquarters
Tokyo
Website
Employees (FY)
422
Founded
2012
ISIN
JP3386550002
FIGI
BBG0087C9G58
GMO Financial Holdings, Inc. engages in the management of its group companies that are in securities and foreign exchange (FX) trading businesses. It operates through the following segments: Securities and FX, Virtual Currency, and Others. The Securities and FX segment provides financial products trading services such as Internet securities trading and FX trading. The Virtual Currency segment offers currency-related trading services such as buying and selling of virtual currency and margin trading. The Others segment includes systems-related business. The company was founded on January 4, 2012 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 7177 is 745 JPY — it has increased by 0.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange GMO FINANCIAL HOLDINGS INC stocks are traded under the ticker 7177.
GMO FINANCIAL HOLDINGS INC is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
7177 stock is 0.67% volatile and has beta coefficient of 0.63. Check out the list of the most volatile stocks — is GMO FINANCIAL HOLDINGS INC there?
GMO FINANCIAL HOLDINGS INC revenue for the last quarter amounts to 9.18 B JPY despite the estimated figure of 9.18 B JPY. In the next quarter revenue is expected to reach 11.31 B JPY.
Yes, you can track GMO FINANCIAL HOLDINGS INC financials in yearly and quarterly reports right on TradingView.
7177 stock has fallen by 1.06% compared to the previous week, the month change is a 5.46% fall, over the last year GMO FINANCIAL HOLDINGS INC has showed a 21.73% increase.
7177 net income for the last quarter is 1.11 B JPY, while the quarter before that showed 2.95 B JPY of net income which accounts for −62.31% change. Track more GMO FINANCIAL HOLDINGS INC financial stats to get the full picture.
Today GMO FINANCIAL HOLDINGS INC has the market capitalization of 88.61 B, it has decreased by 0.67% over the last week.
GMO FINANCIAL HOLDINGS INC dividend yield was 4.36% in 2023, and payout ratio reached 50.15%. The year before the numbers were 4.11% and 197.05% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 7177 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GMO FINANCIAL HOLDINGS INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 422.00 employees. See our rating of the largest employees — is GMO FINANCIAL HOLDINGS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GMO FINANCIAL HOLDINGS INC technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GMO FINANCIAL HOLDINGS INC stock shows the buy signal. See more of GMO FINANCIAL HOLDINGS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GMO FINANCIAL HOLDINGS INC EBITDA is 16.91 B JPY, and current EBITDA margin is 33.48%. See more stats in GMO FINANCIAL HOLDINGS INC financial statements.